Julius Knowles - 01 Jun 2021 Form 4 Insider Report for Keros Therapeutics, Inc. (KROS)

Role
Director
Signature
/s/ Keith Regnante, Attorney-in-Fact
Issuer symbol
KROS
Transactions as of
01 Jun 2021
Net transactions value
-$1,403,553
Form type
4
Filing time
03 Jun 2021, 20:06:14 UTC
Previous filing
20 Jan 2023
Next filing
08 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KROS Common Stock Sale $119,837 -2,309 -0.4% $51.90 569,996 01 Jun 2021 See footnote F1, F2, F3
transaction KROS Common Stock Sale $78,058 -1,504 -0.39% $51.90 381,701 01 Jun 2021 See footnote F1, F2, F4
transaction KROS Common Stock Sale $123,628 -2,345 -0.41% $52.72 567,651 01 Jun 2021 See footnote F1, F3, F5
transaction KROS Common Stock Sale $80,714 -1,531 -0.4% $52.72 380,170 01 Jun 2021 See footnote F1, F4, F5
transaction KROS Common Stock Sale $34,036 -633 -0.11% $53.77 567,018 01 Jun 2021 See footnote F1, F3, F6
transaction KROS Common Stock Sale $22,261 -414 -0.11% $53.77 379,756 01 Jun 2021 See footnote F1, F4, F6
transaction KROS Common Stock Sale $2,513 -46 -0.01% $54.62 566,972 01 Jun 2021 See footnote F1, F3
transaction KROS Common Stock Sale $1,639 -30 -0.01% $54.62 379,726 01 Jun 2021 See footnote F1, F4
transaction KROS Common Stock Sale $239,042 -4,944 -0.87% $48.35 562,028 02 Jun 2021 See footnote F1, F3, F7
transaction KROS Common Stock Sale $155,929 -3,225 -0.85% $48.35 376,501 02 Jun 2021 See footnote F1, F4, F7
transaction KROS Common Stock Sale $66,156 -1,343 -0.24% $49.26 560,685 02 Jun 2021 See footnote F1, F3, F8
transaction KROS Common Stock Sale $43,053 -874 -0.23% $49.26 375,627 02 Jun 2021 See footnote F1, F4, F8
transaction KROS Common Stock Sale $27,938 -553 -0.1% $50.52 560,132 02 Jun 2021 See footnote F1, F3, F9
transaction KROS Common Stock Sale $18,238 -361 -0.1% $50.52 375,266 02 Jun 2021 See footnote F1, F4, F9
transaction KROS Common Stock Sale $7,100 -138 -0.02% $51.45 559,994 02 Jun 2021 See footnote F1, F3, F10
transaction KROS Common Stock Sale $4,682 -91 -0.02% $51.45 375,175 02 Jun 2021 See footnote F1, F4, F10
transaction KROS Common Stock Sale $88,799 -1,862 -0.33% $47.69 558,132 03 Jun 2021 See footnote F1, F3, F11
transaction KROS Common Stock Sale $57,848 -1,213 -0.32% $47.69 373,962 03 Jun 2021 See footnote F1, F4, F11
transaction KROS Common Stock Sale $140,454 -2,917 -0.52% $48.15 555,215 03 Jun 2021 See footnote F1, F3, F12
transaction KROS Common Stock Sale $91,629 -1,903 -0.51% $48.15 372,059 03 Jun 2021 See footnote F1, F4, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.39 to $52.38 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8), (9), (10), (11) and (12).
F3 The securities are held by Partners Innovation Fund, LLC ("PIF I"). Partners Innovation Fund, LLC ("Partners GP I") is the ultimate general partner of PIF I. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP I and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF I.
F4 The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC ("Partners GP II") is the ultimate general partner of PIF II. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP II and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF II.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.40 to $53.37 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.41 to $54.32 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.87 to $48.85 inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.89 to $49.86 inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.02 to $50.88 inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.21 to $51.57 inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.98 inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.44 inclusive.